Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
144.00
Ask:
145.00
Spread: 1.00 (0.694%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Update

14 Jul 2022 07:00

RNS Number : 4114S
Xaar PLC
14 July 2022
 

 

Xaar plc

 

Trading Update

 

Xaar plc ("Xaar", the "Group" or the "Company"), the leading inkjet printing technology group, today announces a trading update for the six months ended 30 June 2022.

 

 

TRADING

 

Continued strong trading and momentum

 

· Revenue for the period is expected to be approximately £37 million, representing an increase of 41% relative to H1 2021 (14% organic excluding FFEI and Megnajet) and 12% relative to H2 2021 (11% organic excluding Megnajet)

 

· Strong revenue growth with improved gross margins and successful cost management actions mean the Board expects the Group to be on track to report an adjusted profit for the current year in line with its expectations

 

Further operational and strategic progress across the Group

 

· Printhead division performed well with strong growth in Europe and US offsetting a Covid-related slowdown in China. We remain on track for the aqueous printhead launch in Q4 2022

 

· The new printbar product developed by FFEI, Xaar Versatex, was successfully launched, whilst the acquisition of Megnajet further strengthens the Group's vertical integration capability

 

· Product Print Systems business ("EPS") delivered a strong, improved performance with revenue and margin growth

 

Successfully mitigating cost inflation

 

· Further investment in inventory has allowed the Group to successfully mitigate cost inflation and increases supply chain resilience

 

· Sales price increases have further assisted in off-setting the effects of cost inflation

 

· Additional management initiatives are helping in reducing costs and increasing operational efficiency while cutting energy use supporting Xaar's 'net zero' commitments

 

 

BALANCE SHEET AND LIQUIDITY

 

The Group remains well capitalised with a strong balance sheet and cash position. Investment has been made in acquiring Megnajet and key capital projects together with increasing working capital to protect the Group's supply chain and ability to deliver products on time. Net cash at 30 June 2022, was £12.6 million, in line with management expectations.

 

 

John Mills, Chief Executive Officer, commented:

 

"We are really pleased to have achieved a strong performance in the first half of the year in line with our expectations. We are on target, seeing positive momentum continuing to improve performance across the Group.

 

We continue to make strategic and operational progress and remain on track to delivering long-term profitable growth.

 

Despite a continued uncertain macro-economic outlook, we remain confident and excited by the future and look forward to the launch of our aqueous printhead later in the year." 

 

 

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Tulchan Communications

Giles Kernick

Olivia Lucas

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKNBKCBKDCOD
Date   Source Headline
27th Aug 20157:01 amRNS2015 Interim Results
26th Aug 20156:01 pmRNSHolding(s) in Company
3rd Aug 201510:25 amRNSTotal Voting Rights
8th Jul 20157:00 amRNSScheduled Trading Statement
7th Jul 20153:28 pmRNSHolding(s) in Company
1st Jul 20151:36 pmRNSBlocklisting Interim Review
1st Jul 20151:33 pmRNSTotal Voting Rights
5th Jun 20157:00 amRNSDirectorate Change
1st Jun 20151:16 pmRNSTotal Voting Rights
1st May 20151:27 pmRNSDirector Shareholding
1st May 201512:37 pmRNSTotal Voting Rights
27th Apr 201510:00 amRNSDirectorate Change
8th Apr 20153:58 pmRNSDirector/PDMR Shareholding
7th Apr 20154:33 pmRNSGrant of Options
7th Apr 20154:31 pmRNSDirector/PDMR Shareholding
31st Mar 20155:23 pmRNSTotal Voting Rights
27th Mar 201510:08 amRNSDirectorate Change
24th Mar 20152:15 pmRNSDirector/PDMR Shareholding
19th Mar 20157:00 amRNS2014 Full Year Results
3rd Mar 20159:51 amRNSTotal Voting Rights
2nd Mar 20157:00 amRNSDirector Appointment
16th Feb 20152:09 pmRNSDirectorate Change
2nd Feb 20155:52 pmRNSTotal Voting Rights
5th Jan 20157:00 amRNSAppointment of CEO
2nd Jan 201510:00 amRNSBlocklisting Interim Review
2nd Jan 201510:00 amRNSTotal Voting Rights
19th Dec 20142:34 pmRNSHolding(s) in Company
17th Dec 20147:00 amRNSTrading Update
16th Dec 20143:58 pmRNSHolding(s) in Company
15th Dec 201411:01 amRNSHolding(s) in Company
12th Dec 20149:31 amRNSHolding(s) in Company
1st Dec 20145:32 pmRNSTotal Voting Rights
27th Nov 20144:22 pmRNSHolding(s) in Company
3rd Nov 201412:34 pmRNSTotal Voting Rights
3rd Nov 201410:01 amRNSHolding(s) in Company
27th Oct 201412:48 pmRNSDirector/PDMR Shareholding
10th Oct 20149:57 amRNSHolding(s) in Company
7th Oct 20144:26 pmRNSHolding(s) in Company
6th Oct 20142:35 pmRNSHolding(s) in Company
3rd Oct 20145:12 pmRNSHolding(s) in Company
2nd Oct 20147:00 amRNSInterim Management Statement
1st Oct 20143:57 pmRNSTotal Voting Rights
30th Sep 20149:12 amRNSGrant of Options - Share Save
16th Sep 20142:56 pmRNSHolding(s) in Company
9th Sep 20143:11 pmRNSHolding(s) in Company
8th Sep 20143:02 pmRNSDirector/PDMR Shareholding
1st Sep 20145:41 pmRNSTotal Voting Rights
28th Aug 20147:00 amRNS2014 Interim Results
1st Aug 20141:11 pmRNSTotal Voting Rights
17th Jul 20147:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.